We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Antibody-Produced Ozone Found in Humans

By Biotechdaily staff writers
Posted on 14 Mar 2003
Researchers have found that antibodies bound to human neutrophils are the source of antimicrobial ozone, which is generated by the antibodies from singlet oxygen produced by the neutrophils. Their findings were published February 24, 2003, in the online edition of the Proceedings of the National Academy of Science.

Prior reports from a research group at the The Scripps Research Institute (La Jolla, CA, USA) had established that antibodies were able to produce ozone and other chemical oxidants from the reactive singlet form of oxygen, and that the oxidants produced by antibodies could destroy bacteria by punching holes in their cell walls.

In the current study, the investigators showed that the likely source of singlet oxygen was white blood cell neutrophils. Studying antibody binding to neutrophils, they found that the process was independent of surface antibody concentration down to 50% of the resting concentration, suggesting that surface IgG was highly efficient at intercepting the neutrophil-generated singlet oxygen. Antibody binding enhanced the antibacterial effect of the neutrophils. In addition to killing the bacteria themselves, the neutrophils provided singlet oxygen to the antibodies, which augmented the effect of the neutrophils by converting the singlet oxygen into ozone.

"It is a tremendously efficient chemical and biological process,” explained senior author Dr. Paul Wentworth, associate professor of chemistry at the Scripps Research Institute. "The presence of ozone in the human body may be linked to inflammation, and therefore this work may have tremendous ramifications for treating inflammatory diseases.”




Related Links:
The Scripps Research Institute

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Urine Analyzer
respons® UDS100
New
Thyroid Test
Anti-Thyroid EIA Test

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
14 Mar 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
14 Mar 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
14 Mar 2003  |   BioResearch